Literature DB >> 9448764

Gastrointestinal leiomyoma and leiomyosarcoma: CT differentiation.

H J Chun1, J Y Byun, K A Chun, S E Rha, S E Jung, J M Lee, K S Shinn.   

Abstract

PURPOSE: Our goal was to evaluate CT efficacy in differentiating gastrointestinal leiomyoma and leiomyosarcoma.
METHOD: We retrospectively reviewed CT scans of 45 patients (21 men, 24 women, mean age 55 years) with surgically proven gastrointestinal leiomyomas (n = 21) and leiomyosarcomas (n = 24) with respect to size, contour, enhancing pattern, mesenteric fat infiltration, calcification, ulceration, regional lymphadenopathy, direct invasion, distant metastasis, and growth pattern after visual inspection by two radiologists in agreement. On the basis of these CT features, subjective diagnosis was also categorized into three groups (Group I: probably benign, Group II: probably malignant, Group III: diagnostic malignant). The results were compared with the final histopathologic diagnosis.
RESULTS: In addition to the features of direct invasion and distant metastasis suggesting diagnostic malignancy, the CT features favoring malignancy with statistical significance included larger size (> 5 cm), lobulated contour, heterogeneous enhancement, mesenteric fat infiltration, ulceration, regional lymphadenopathy, and exophytic growth pattern (p < 0.005). However, calcification was not significant in differentiating the two entities (p = 0.25163). A subjective analysis revealed 89% sensitivity, 85% specificity, and 87% accuracy for diagnosis of leiomyosarcoma.
CONCLUSION: CT features are useful in differentiating leiomyoma and leiomyosarcoma in gastrointestinal tract.

Entities:  

Mesh:

Year:  1998        PMID: 9448764     DOI: 10.1097/00004728-199801000-00012

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  4 in total

Review 1.  Gastrointestinal stromal tumors (GISTs): an updated experience.

Authors:  Anastasios Machairas; Eva Karamitopoulou; Dimitrios Tsapralis; Theodore Karatzas; Nickolas Machairas; Evangelos P Misiakos
Journal:  Dig Dis Sci       Date:  2010-08-20       Impact factor: 3.199

2.  Contribution of CT to treatment planning in patients with GIST.

Authors:  A Rimondini; M Belgrano; G Favretto; A Spivach; A Sartori; F Zanconati; M A Cova
Journal:  Radiol Med       Date:  2007-07-26       Impact factor: 3.469

3.  Rectal gastrointestinal stromal tumour: What do we know in 2017? A systematic review protocol.

Authors:  Surennaidoo Naiken; Ailsa Craig; Noémie Guedj; Nelson Peixoto; Guillaume Zufferey
Journal:  Int J Surg Protoc       Date:  2017-12-26

4.  Current management and prognostic features for gastrointestinal stromal tumor (GIST).

Authors:  Gurpreet Lamba; Ridhi Gupta; Byung Lee; Samir Ambrale; Delong Liu
Journal:  Exp Hematol Oncol       Date:  2012-06-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.